VDR and uveitis: By suppressing interleukin (IL)-17production, a factor implicated in the pathogenesis of many autoimmune conditions,including uveitis, and inhibiting T helper-17 responses, VDR agonists may holdtherapeutic potential for uveitis treatment(13).